President & CEO of Medpace Holdings Inc (30-Year Financial, Insider Trades) August J. Troendle (insider trades) sold 8,582 shares of MEDP on 07/13/2020 at an average price of $100.4 a share. The total sale was $861,633.
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings Inc has a market cap of $3.41 billion; its shares were traded at around $96.38 with a P/E ratio of 33.23 and P/S ratio of 4.08.
CEO Recent Trades:
- President & CEO, 10% Owner August J. Troendle sold 8,582 shares of MEDP stock on 07/13/2020 at the average price of $100.4. The price of the stock has decreased by 4% since.
Directors and Officers Recent Trades:
- 10% Owner Investors, Llc Medpace sold 8,582 shares of MEDP stock on 07/13/2020 at the average price of $100.4. The price of the stock has decreased by 4% since.
For the complete insider trading history of MEDP, click here
.